Intera Atlas
Run match
Sites / IMA Clinical Research
Is this you?

Request access for IMA Clinical Research with your @imaresearch.com work email. Intera will contact you to verify and set up your account — nothing auto-publishes.

Request account

IMA Clinical Research

Unclaimed profile

Site Network · Tarrytown, NY · ~150+ satellite sites, 15+ full-service sites sites

WebsiteLinkedInRank for protocol
Intera lens
ICP 9Lift (cardio sample) 0.30Recruit soph 0.29
Quality Scorecard (1–100)
Overall65Recruit67Ops69Sponsor59Ther62

Performance (observed)

Historical trials
153
Completed
68
Terminated/Withdrawn
10
Completion rate
87%
Active now
73
Phase 2
53
Phase 3
89
Realized enrollment
461,439
First study year
2006
Years active
20
Match confidence
low
Enrollment velocity (inf)
23,072

Therapeutic

Areas
Multiple (psychiatry, neurology, CNS, metabolic disorders, depression, memory loss, obesity, diverse conditions)
Specialties
Multi-specialty; CNS, sleep disorders, pain, general medicine
Breadth (conditions)
133
Languages
English + Spanish (detected)
States
Nationwide US coverage (sites in TX, NJ, NY, NM, NC, LA, AZ, NV, FL, WV, and others)

Recruitment (web observed)

Trial Finder
Yes
Patient database
300K+
Advertises recruitment
Yes
SEO
Moderate; acquisition news
Capability notes
400K+ patient database, access to millions, proven diverse enrollment, high-volume recruitment, site proximity advantage

Relationships

Sponsors
Eli Lilly and Company; Pfizer; Boehringer Ingelheim; Novo Nordisk A/S; Merck Sharp & Dohme LLC; ModernaTX, Inc.
CROs
ICON Clinical Research; IQVIA Pty Ltd; Worldwide Clinical Trials
Owner / parent
The IMA Group (35+ years, 150+ offices, diversified services division)
Acquisitions
Chicago Research Center (2025); Accelemed Research Austin; Clinical Trials of America sites (2023)
Expansion
Y - acquisitions 2023-2025 (Chicago Research Center Oct 2025; Accelemed 2023; CTA sites 2023)
Recent hiring
Y - 15 clinical investigators hired 2023; VP hired

Capacity & people

Investigators
—
Coordinators
—
CEO
Dr. Mark I. Weinberger, PhD, MPH
VP Clinical Ops
Dana Poff (Executive Vice President, Clinical Research)
VP Site Ops
Unknown
VP Recruitment
Debra Nichols (Chief Commercial Officer)

Tech & DCT

eSource
Yes
Builds tech
Builds Internally
DCT / decentralized
Y - hybrid, site-based, fully decentralized options
Tech stack
Patient-centric platform for flexible trial models, data quality systems
Recruiting visible
Y

Notes

Large nationwide network (150+ satellite, 15+ full-service). 35+ year track record. Strong recruitment capability (400K+ database, diverse populations). Explicit DCT support (site-based, hybrid, fully decentralized). Patient-centric tech platform. Multiple therapeutic areas. High-volume potential. Excellent fit: Multi-site nationwide, proven recruitment, DCT-forward, diverse populations, tech-enabled, growth-focused, high-volume enrollment capability. [Validated: 6 active recruiting cardiometabolic trials on ClinicalTrials.gov.]

Recommendation features (sample indication)

Ind fit 0.42Liftability 0.30Overall65

FUTURE MOAT: absolute enrollment rates, funnel CPR, measured SSU, screen-fail reasons.